EUVIMEDEUVIMED entdecken
Open Access

Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR

Juan Zhang, Bei Liu, Changwei Xu, Chenchen Ji, Anan Yin, Yifeng Liu, Yan Yao, Bowen Li, Tangdong Chen, Liangliang Shen iD, Yuanming Wu

Neuro-Oncology · 05.04.2024 · 26 (4) · 684-700

DOI: 10.1093/neuonc/noad233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 09.12.2023. Verfasst von Juan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Cholesterol, Glioma. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Key Innovative Project in Shaanxi, Shaanxi Youth Science and Technology New Star Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dysregulation of cholesterol metabolism is a significant characteristic of glioma, yet the underlying mechanisms are largely unknown. N6-methyladenosine (m6A) modification has been implicated in promoting tumor development and progression. The aim of this study was to determine the key m6A regulatory proteins involved in the progression of glioma, which is potentially associated with the reprogramming of cholesterol homeostasis.

Methods

Bioinformatics analysis was performed to determine the association of m6A modification with glioma malignancy from The Cancer Genome Atlas and Genotype-Tissue Expression datasets. Glioma stem cell (GSC) self-renewal was determined by tumor sphere formation and bioluminescence image assay. RNA sequencing and lipidomic analysis were performed for cholesterol homeostasis analysis. RNA immunoprecipitation and luciferase reporter assay were performed to determine hnRNPA2B1-dependent regulation of sterol regulatory element-binding protein 2 (SREBP2) and low-density lipoprotein receptor (LDLR) mRNA. The methylation status of hnRNPA2B1 promoter was determined by bioinformatic analysis and methylation-specific PCR assay.

Results

Among the m6A-regulatory proteins, hnRNPA2B1 was demonstrated the most important independent prognostic risk factor for glioma. hnRNPA2B1 ablation exhibited a significant tumor-suppressive effect on glioma cell proliferation, GSC self-renewal and tumorigenesis. hnRNPA2B1 triggers de novo cholesterol synthesis by inducing HMGCR through the stabilization of SREBP2 mRNA. m6A modification of SREBP2 or LDLR mRNA is required for hnRNPA2B1-mediated mRNA stability. The hypomethylation of cg21815882 site on hnRNPA2B1 promoter confers elevated expression of hnRNPA2B1 in glioma tissues. The combination of targeting hnRNPA2B1 and cholesterol metabolism exhibited remarkable antitumor effects, suggesting valuable clinical implications for glioma treatment. Conclusions hnRNPA2B1 facilitates cholesterol uptake and de novo synthesis, thereby contributing to glioma stemness and malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolGliomaHumansSterol Regulatory Element Binding Protein 2RNA, MessengerHomeostasis

Stichwörter der Autor:innen

cholesterol homeostasisglioma stem cellhnRNPA2B1m6A modification

Substanzen

CholesterolSterol Regulatory Element Binding Protein 2RNA, Messenger

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China.
  • Shaanxi Provincial Key Laboratory of Clinical Genetics, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Aerospace Hygiene, School of Aerospace Medicine, Fourth Military Medical University, Xi'an, China.
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Fourth Military Medical University, Xi'an, China.
  • Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

ORCID-Profile: Liangliang Shen

Förderung

  • National Natural Science Foundation of China
  • Key Innovative Project in Shaanxi
  • Shaanxi Youth Science and Technology New Star Project
  • Shaanxi Innovative Research Team for Key Science and Technology
  • China General Technology Group Project
  • State Key Laboratory of Cancer Biology Project

Zitieren

APA

Zhang, J., Liu, B., Xu, C., Ji, C., Yin, A., Liu, Y., Yao, Y., Li, B., Chen, T., Shen, L., & Wu, Y. (2024). Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR. Neuro-Oncology, 26(4), 684-700. https://doi.org/10.1093/neuonc/noad233

Vancouver

Zhang J, Liu B, Xu C, Ji C, Yin A, Liu Y, et al. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR. Neuro-Oncology. 2024;26(4):684-700. doi:10.1093/neuonc/noad233

BibTeX
@article{Zhang2024,
  author = {Zhang, Juan and Liu, Bei and Xu, Changwei and Ji, Chenchen and Yin, Anan and Liu, Yifeng and Yao, Yan and Li, Bowen and Chen, Tangdong and Shen, Liangliang and Wu, Yuanming},
  title = {Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {4},
  pages = {684--700},
  doi = {10.1093/neuonc/noad233}
}
Kostenlos starten →